Current Report on Form 8-K

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SSKWrF9zSb/KqvsBXzyLRH0ojY88OGaDeJOI36EfLluLg42voJEXNOl5TNgr2Iu7 3WS/fwpNido0Mj3PCgD77Q== 0001017062-03-001041.txt : 20030501 0001017062-03-001041.hdr.sgml : 20030501 20030501172558 ACCESSION NUMBER: 0001017062-03-001041 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20030429 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONWIDE HEALTH PROPERTIES INC CENTRAL INDEX KEY: 0000780053 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 953997619 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09028 FILM NUMBER: 03677721 BUSINESS ADDRESS: STREET 1: 610 NEWPORT CENTER DR STREET 2: STE 1150 CITY: NEWPORT BEACH STATE: CA ZIP: 92660-6429 BUSINESS PHONE: 9497184400 MAIL ADDRESS: STREET 1: 610 NEWPORT CENTER DR STREET 2: STE 1150 CITY: NEWPORT BEACH STATE: CA ZIP: 92660-6429 FORMER COMPANY: FORMER CONFORMED NAME: BEVERLY INVESTMENT PROPERTIES INC DATE OF NAME CHANGE: 19890515 8-K 1 d8k.htm CURRENT REPORT ON FORM 8-K Current Report on Form 8-K

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) of the

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): April 29, 2003

NATIONWIDE HEALTH PROPERTIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

Maryland	1-9028	95-3997619
(State or Other	(Commission	(IRS Employer
Jurisdiction of	File Number)	Identification
Incorporation)		No.)

610 Newport Center Drive, Suite 1150, Newport Beach, California 92660-6429

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (949) 718-4400

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

ITEM 5. OTHER EVENTS

On April 29, 2003, we entered into purchase agreements to issue and sell 9,625,000 shares of common stock, par value $0.10 per share, to selected institutional investors, with the assistance of Cohen & Steers Capital Advisors, LLC as a placement agent in a direct placement, which is expected to result in net proceeds of approximately $112,940,000, after we pay expenses of the offering, including placement agent fees and expenses. We will use the proceeds from the offering for general corporate purposes, including the repayment of amounts outstanding under our revolving bank line of credit.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

99.1 Purchase Agreement, dated as of April 29, 2003, by and among European Investors, Inc., the client accounts of European Investors, Inc. as set forth on Schedule A thereto and the Registrant.

99.2 Purchase Agreement, dated as of April 29, 2003, by and between Fidelity Securities Fund: Fidelity Real Estate Income Fund and the Registrant.

99.3 Purchase Agreement, dated as of April 29, 2003, by and among Kensington Investment Group, Inc., the client accounts of Kensington Investment Group, Inc. as set forth on Schedule A thereto and the Registrant.

99.4 Purchase Agreement, dated as of April 29, 2003, by and between Millennium Trading Co. LP and the Registrant.

99.5 Purchase Agreement, dated as of April 29, 2003, by and among Morgan Stanley Investment Management, Inc. on behalf of the client accounts of Morgan Stanley Investment Management, Inc. as set forth on Schedule A thereto and the Registrant.

99.6 Purchase Agreement, dated as of April 29, 2003, by and among Security Capital Research & Management Incorporated, the client accounts of Security Capital Research & Management Incorporated as set forth on Schedule A thereto and the Registrant.

99.7 Purchase Agreement, dated as of April 29, 2003, by and among the Registrant, Teachers Insurance and Annuity Association of America, TIAA-CREF Real Estate Securities Fund and TIAA Life Real Estate Securities Fund, which funds are acting through their investment manager, Teachers Advisors, Inc., and Teachers Advisors, Inc. on behalf of itself (as to paragraph 4 thereto) and each of the funds listed under its name on Schedule A thereto.

99.8 Placement Agency Agreement, dated April 29, 2003, by and between Cohen & Steers Capital Advisors, LLC and the Registrant.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NATIONWIDE HEALTH PROPERTIES, INC.

Date: April 29, 2003	By:	/s/ MARK L. DESMOND
		Name: Mark L. Desmond
		Title: Senior Vice President and Chief Financial Officer

EX-99.1 3 dex991.htm PURCHASE AGREEMENT DATED APRIL 29, 2003 Purchase Agreement dated April 29, 2003

EXHIBIT 99.1

PURCHASE AGREEMENT

This Purchase Agreement (this “Agreement”), dated as of April 29, 2003, is by and among European Investors, Inc. (the “INVESTMENT ADVISER”), the client accounts of the INVESTMENT ADVISER, as set forth on Schedule A (each a “PURCHASER” and collectively the “PURCHASERS”), and Nationwide Health Properties, Inc., a Maryland corporation (the “SELLER”).

WHEREAS, the PURCHASERS desire to purchase from the SELLER, and the SELLER desires to issue and sell to the PURCHASERS, in the aggregate 750,000 shares of common stock of SELLER, par value $0.10 per share (the “Shares”), with the number of Shares acquired by each PURCHASER set forth on Schedule A.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties hereto agree as follows:

1. Purchase and Sale. Subject to the terms and conditions hereof, the PURCHASERS hereby agree to purchase from the SELLER, and the SELLER agrees to issue and sell to the PURCHASERS, the Shares at a price per share of $12.00 for an aggregate purchase amount of $9,000,000 (the “Purchase Price”).

2. Representations and Warranties of PURCHASER. Each PURCHASER represents and warrants with respect to itself that:

(a) Due Authorization. Such PURCHASER is duly authorized to purchase the Shares. This Agreement has been duly authorized, executed and delivered by such PURCHASER and constitutes a legal, valid and binding agreement of such PURCHASER, enforceable against such PURCHASER in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

(b) Prospectus and Prospectus Supplement. Such PURCHASER has received a copy of the SELLER’s Basic Prospectus (as defined below) dated April 19, 1998, and Prospectus Supplement (as defined below) dated April 29, 2003.

(c) Ownership of Shares of Common Stock. As of the date hereof, such PURCHASER, together with its respective subsidiaries and affiliates, does not own 5% or more of the issued and outstanding shares of common stock, par value $0.10 per share, of the SELLER.

3. Representations and Warranties of SELLER. The SELLER represents and

warrants that:

(a) The SELLER meets the requirements for use of Form S-3 under the Securities Act of 1933, as amended (the “Act”). The SELLER’s Registration Statement (as defined below) was declared effective by the by the SEC (as defined below) and the SELLER has filed such post-effective amendments thereto as may be required prior to the execution of this Agreement and each such post-effective amendment became effective. The SEC has not issued, and to the SELLER’s knowledge, the SEC does not intend nor has it threatened to issue, a stop order with respect to the Registration Statement, nor has it otherwise suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, nor, to the SELLER’s knowledge, does it intend or has it threatened to do so. On the effective date, (i) the Registration Statement complied in all material respects with the requirements of the Act and the rules and regulations promulgated under the Act (the “Regulations”); at the effective date the Basic Prospectus (as defined below) complied, and at the Closing (as defined below) the Prospectus (as defined below) will comply, in all material respects with the requirements of the Act and the Regulations; and (ii) the Registration Statement at the effective date and as amended or supplemented on the date hereof and at the Closing did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus as of any such time, did not, does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall not apply to statements in or omissions from the Prospectus made in reliance upon and in conformity with information furnished to the SELLER in writing by any of the PURCHASERS or Cohen & Steers Capital Advisors, LLC, in its capacity as placement agent, and their respective affiliates, expressly for use in the Prospectus. As used in this Agreement, the term “Registration Statement” means the “shelf” registration statement on Form S-3 (File No. 333-17061) as declared effective by the Securities and Exchange Commission (the “SEC”), including exhibits, financial statements, schedules and documents incorporated by reference therein. The term “Basic Prospectus” means the prospectus included in the Registration Statement. The term “Prospectus Supplement” means the prospectus supplement specifically relating to the Shares as shall be filed with the SEC pursuant to Rule 424 under the Act in connection with the sale of the Shares hereunder. The term “Prospectus” means the Basic Prospectus and the Prospectus Supplement. Any reference in this Agreement to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein as of the date hereof or the date of the Prospectus, as the case may be, and any reference herein to any amendment or

-2-

supplement to the Registration Statement or the Prospectus shall be deemed to refer to and include any documents filed after such date and through the date of such amendment or supplement under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and so incorporated by reference.

(b) Since the date as of which information is given in the Registration Statement and the Prospectus, except as otherwise stated therein, (i) there has been no material adverse change or any development involving a prospective material adverse change in or affecting the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the SELLER and the subsidiaries of the SELLER, if any (the “Subsidiaries”) considered as one enterprise, whether or not arising in the ordinary course of business, (ii) there have been no transactions entered into by the SELLER or any of its Subsidiaries, other than those in the ordinary course of business, which are material with respect to the SELLER and its Subsidiaries considered as one enterprise, and (iii) other than regular quarterly dividends, there has been no dividend or distribution of any kind declared, paid or made by the SELLER on any class of its shares of capital stock.

(c) The SELLER has been duly organized and is validly existing in good standing under the laws of the State of Maryland. Each Subsidiary of the SELLER which is a significant subsidiary (each a “Significant Subsidiary”) as defined in Rule 405 of Regulation C of the Act has been duly organized and is validly existing in good standing under the laws of its jurisdiction of organization. Each of the SELLER and its Significant Subsidiaries has corporate, limited partnership or limited liability company power and authority, as the case may be, to own and lease its properties and to conduct its business as described in the Prospectus; and each of the SELLER and its Significant Subsidiaries is duly qualified to transact business in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify would not have a material adverse effect on the condition, financial or otherwise, or the earnings, business affairs or business prospects of the SELLER and its Significant Subsidiaries considered as one enterprise.

(d) As of the date hereof, the authorized capital stock of the SELLER consisted of 100,000,000 shares of common stock, par value $0.10 per share, and 5,000,000 shares of preferred stock, par value $1.00 per share, of which 49,172,216 shares of common stock and 1,000,000 shares of 7.677% Series A Cumulative Preferred Stock are issued and outstanding. The issued and outstanding shares of common stock and preferred stock of SELLER have been duly authorized and validly issued and are fully paid and non-assessable; the Shares have been duly authorized, and when issued and delivered as contemplated hereby, will be validly issued, fully

-3-

paid and non-assessable and will be listed, subject to notice of issuance, on the New York Stock Exchange, effective as of the Closing; the Shares conform to all statements relating thereto contained in the Prospectus; and the issuance of the Shares is not subject to preemptive or other similar rights.

(e) Neither the SELLER nor any of its Significant Subsidiaries is in violation of its organizational documents or in default in the performance or observance of any material obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, loan agreement, note, lease or other instrument or agreement to which the SELLER or any of its Significant Subsidiaries is a party or by which it or any of them may be bound, or to which any of the property or assets of the SELLER or any of its Significant Subsidiaries is subject where such violation or default would have a material adverse effect on the condition, financial or otherwise, or the earnings, business affairs or business prospects of the SELLER and its Subsidiaries considered as one enterprise; and, the execution, delivery and performance of this Agreement, and the issuance and delivery of the Shares and the consummation of the transactions contemplated herein have been duly authorized by all necessary corporate action and will not conflict with or constitute a material breach of, or default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the SELLER or any of its Significant Subsidiaries pursuant to, any contract, indenture, mortgage, loan agreement, note, lease or other instrument or agreement to which the SELLER or any of its Significant Subsidiaries is a party or by which it or any of them may be bound, or to which any of the property or assets of the SELLER or any of its Significant Subsidiaries is subject, nor will any such action result in any violation of the provisions of the Amended and Restated Articles of Incorporation, as amended, Bylaws or other organizational documents of the SELLER or any of its Significant Subsidiaries or any applicable law, administrative regulation or administrative or court decree.

(f) The SELLER is organized in conformity with the requirements for qualification and, as of the date hereof and as of the Closing, operates in a manner that qualifies it as a “real estate investment trust” under the Internal Revenue Code of 1986, as amended, and the rules and regulations thereunder and will be so qualified after giving effect to the sale of the Shares.

(g) The SELLER is not required to be registered under the Investment Company Act of 1940, as amended.

-4-

of its Subsidiaries, which is required to be disclosed in the Prospectus (other than as disclosed therein), or which is more likely than not to result in any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the SELLER and its Subsidiaries considered as one enterprise, or which is more likely than not to materially and adversely affect their respective property or assets or which is more likely than not to materially and adversely affect the consummation of this Agreement; all pending legal or governmental proceedings to which the SELLER or any of its Subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the Prospectus, including ordinary routine litigation incidental to its business, are, considered in the aggregate, not material to the business of the SELLER and its Subsidiaries considered as one enterprise.

(i) No authorization, approval or consent of any court or United States federal or state governmental authority or agency is necessary in connection with the sale of the Shares hereunder, except such as may be required under the Act or the Regulations or state securities laws or real estate syndication laws.

(j) The SELLER and its Subsidiaries possess such material certificates, authorities or permits issued by the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct the business now conducted by them, and neither the SELLER nor any of its Subsidiaries has received any notice of proceedings relating to the revocation or modification of any such certificate, authority or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would materially and adversely affect the condition, financial or otherwise, or the earnings, business affairs or business prospects of the SELLER and its Subsidiaries considered as one enterprise, nor, to the knowledge of the SELLER, are any such proceedings threatened or contemplated.

(k) The SELLER has corporate power and corporate authority to enter into this Agreement, and this Agreement has been duly authorized, executed and delivered by the SELLER and constitutes a legal, valid and binding agreement of SELLER, enforceable against SELLER in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

(l) The SELLER has good and marketable title to all of the properties and assets reflected in the audited financial statements contained in the Prospectus, subject

-5-

to no lien, mortgage, pledge or encumbrance of any kind except those reflected in such financial statements (or as otherwise described in the Prospectus) or which are not material or which constitute customary provisions of mortgage loans secured by the SELLER’s properties creating obligations of the SELLER with respect to proceeds of the properties, environmental liabilities and other customary protections for the mortgagees.

4. Representation and Warranty of the INVESTMENT ADVISER. To induce the SELLER to enter into this Agreement, the INVESTMENT ADVISER hereby represents and warrants that:

(a) It is an investment adviser duly registered with the SEC under the Investment Advisers Act of 1940.

(b) It has been duly authorized to act as investment adviser on behalf of each PURCHASER.

(d) This Agreement has been duly executed and delivered by it and constitutes a legal, valid and binding agreement of INVESTMENT ADVISER, enforceable against it in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

5. Conditions to Obligations of the Parties. As a condition to Closing, (i) each of the representations and warranties of the parties hereto shall be true and correct in all material respects, (ii) the New York Stock Exchange shall have approved the Shares for listing upon notice of issuance, (iii) the PURCHASERS shall have received an opinion from O’Melveny & Myers LLP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit A, (iv) the PURCHASERS shall have received an opinion from Venable, Baetjer & Howard, LP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit B and (v) the PURCHASERS shall have received a comfort letter from Ernst & Young LLP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit C.

-6-

the Closing, settlement shall occur through Jeffries & Company, or an affiliate thereof, on a delivery versus payment basis through the DTC ID System.

7. Governing Law. This Agreement shall be construed in accordance with and governed by the substantive laws of the State of New York, without regard to conflict of laws principles.

8. Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and may be amended only in a writing that is executed by each of the parties hereto.

9. Counterparts. This Agreement may be executed in separate counterparts, each of which shall be deemed an original, and all of which together shall be deemed to constitute one and the same instrument.

-7-

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the date first above written.

NATIONWIDE HEALTH PROPERTIES, INC.,

a Maryland corporation

By: /s/ MARK L. DESMOND

Name: Mark L. Desmond

Title: Senior Vice President & Chief Financial Officer

EUROPEAN INVESTORS, INC., on behalf of

itself and each PURCHASER set forth on

Schedule A

By: /s/ ALFRED C. OTERO

Name: Alfred C. Otero

Title: Managing Director

-8-

EX-99.2 4 dex992.htm PURCHASE AGREEMENT DATED APRIL 29, 2003 Purchase Agreement dated April 29, 2003

EXHIBIT 99.2

PURCHASE AGREEMENT

This Purchase Agreement (this “Agreement”), dated as of April 29, 2003, is by and between Fidelity Securities Fund: Fidelity Real Estate Income Fund ( the “PURCHASER”) and Nationwide Health Properties, Inc., a Maryland corporation (the “SELLER”).

WHEREAS, the PURCHASER desires to purchase from the SELLER, and the SELLER desires to issue and sell to the PURCHASER, 100,000 shares of common stock of SELLER, par value $0.10 per share (the “Shares”).

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties hereto agree as follows:

1. Purchase and Sale. Subject to the terms and conditions hereof, the PURCHASER hereby agrees to purchase from the SELLER, and the SELLER agrees to issue and sell to the PURCHASER the Shares at a price per share of $12.00 for an aggregate purchase amount of $1,200,000 (the “Purchase Price”).

2. Representations and Warranties of PURCHASER. The PURCHASER represents and warrants that:

(a) Due Authorization. The PURCHASER is duly authorized to purchase the Shares. This Agreement has been duly authorized, executed and delivered by the PURCHASER and constitutes a legal, valid and binding agreement of the PURCHASER, enforceable against the PURCHASER in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

(b) Prospectus and Prospectus Supplement. The PURCHASER has received a copy of the SELLER’s Basic Prospectus (as defined below) dated April 19, 1998, and Prospectus Supplement (as defined below) dated April 29, 2003.

(c) Ownership of Shares of Common Stock. As of the date hereof, the PURCHASER, together with its subsidiaries and affiliates does not own 5% or more of the issued and outstanding shares of common stock, par value $0.10 per share, of the SELLER.

3. Representations and Warranties of SELLER. The SELLER represents and warrants that:

(a) The SELLER meets the requirements for use of Form S-3 under the Securities Act of 1933, as amended (the “Act”). The SELLER’s Registration Statement (as defined below) was declared effective by the by the SEC (as defined below) and the SELLER has filed such post-effective amendments thereto as may be required prior to the execution of this Agreement and each such post-effective amendment became effective. The SEC has not issued, and to the SELLER’s knowledge, the SEC does not intend nor has it threatened to issue, a stop order with respect to the Registration Statement, nor has it otherwise suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, nor, to the SELLER’s knowledge, does it intend or has it threatened to do so. On the effective date, (i) the Registration Statement complied in all material respects with the requirements of the Act and the rules and regulations promulgated under the Act (the “Regulations”); at the effective date the Basic Prospectus (as defined below) complied, and at the Closing (as defined below) the Prospectus (as defined below) will comply, in all material respects with the requirements of the Act and the Regulations; and (ii) the Registration Statement at the effective date and as amended or supplemented on the date hereof and at the Closing did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus as of any such time, did not, does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall not apply to statements in or omissions from the Prospectus made in reliance upon and in conformity with information furnished to the SELLER in writing by the PURCHASER or Cohen & Steers Capital Advisors, LLC, in its capacity as placement agent, and their respective affiliates, expressly for use in the Prospectus. As used in this Agreement, the term “Registration Statement” means the “shelf” registration statement on Form S-3 (File No. 333-17061) as declared effective by the Securities and Exchange Commission (the “SEC”), including exhibits, financial statements, schedules and documents incorporated by reference therein. The term “Basic Prospectus” means the prospectus included in the Registration Statement. The term “Prospectus Supplement” means the prospectus supplement specifically relating to the Shares as shall be filed with the SEC pursuant to Rule 424 under the Act in connection with the sale of the Shares hereunder. The term “Prospectus” means the Basic Prospectus and the Prospectus Supplement. Any reference in this Agreement to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein as of the date hereof or the date of the Prospectus, as the case may be, and any reference herein to any amendment or supplement to the Registration Statement or the Prospectus shall be deemed to refer to and include any documents filed after such date and through the date of such amendment or

-2-

supplement under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and so incorporated by reference.

-3-

relating thereto contained in the Prospectus; and the issuance of the Shares is not subject to preemptive or other similar rights.

(g) The SELLER is not required to be registered under the Investment Company Act of 1940, as amended.

-4-

change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the SELLER and its Subsidiaries considered as one enterprise, or which is more likely than not to materially and adversely affect their respective property or assets or which is more likely than not to materially and adversely affect the consummation of this Agreement; all pending legal or governmental proceedings to which the SELLER or any of its Subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the Prospectus, including ordinary routine litigation incidental to its business, are, considered in the aggregate, not material to the business of the SELLER and its Subsidiaries considered as one enterprise.

-5-

material or which constitute customary provisions of mortgage loans secured by the SELLER’s properties creating obligations of the SELLER with respect to proceeds of the properties, environmental liabilities and other customary protections for the mortgagees.

4. Conditions to Obligations of the Parties. As a condition to Closing, (i) each of the representations and warranties of the parties hereto shall be true and correct in all respects, (ii) the New York Stock Exchange shall have approved the Shares for listing upon notice of issuance, (iii) the PURCHASER shall have received an opinion from O’Melveny & Myers LLP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit A, (iv) the PURCHASER shall have received an opinion from Venable, Baetjer and Howard, LP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit B and (v) the PURCHASER shall have received a comfort letter from Ernst & Young LLP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit C.

5. Closing. The transactions contemplated hereby shall be consummated on May 2, 2003, or such other time as shall be agreed upon by the PURCHASER and the SELLER (such time and date of payment and delivery being herein called the “Closing”). At the Closing, settlement shall occur through Jeffries & Company, or an affiliate thereof, on a delivery versus payment basis through the DTC ID System.

6. Governing Law. This Agreement shall be construed in accordance with and governed by the substantive laws of the State of New York, without regard to conflict of laws principles.

7. Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and may be amended only in a writing that is executed by each of the parties hereto.

8. Counterparts. This Agreement may be executed in separate counterparts, each of which shall be deemed an original, and all of which together shall be deemed to constitute one and the same instrument.

9. Publicity. The SELLER agrees that it shall not disclose the investment by the PURCHASER or otherwise use the PURCHASER’S or its affiliates’ name or trademark without the prior written consent of the PURCHASER; provided, however, that the SELLER shall be permitted to include this Agreement in any filings with the SEC.

-6-

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the date first above written.

NATIONWIDE HEALTH PROPERTIES, INC., a Maryland corporation

By:		/s/ MARK L. DESMOND
		Name: Mark L. Desmond Title: Senior Vice President & Chief Financial Officer

FIDELITY SECURITIES FUND: FIDELITY REAL ESTATE INCOME FUND

By:		/s/ MARK OSTERHELD
		Name: Mark Osterheld Title: Assistant Treasurer

-7-

EX-99.3 5 dex993.htm PURCHASE AGREEMENT DATED APRIL 29, 2003 Purchase Agreement dated April 29, 2003

EXHIBIT 99.3

PURCHASE AGREEMENT

This Purchase Agreement (this “Agreement”), dated as of April 29, 2003, is by and among Kensington Investment Group, Inc. (“INVESTMENT ADVISER”), the client accounts of INVESTMENT ADVISER, as set forth on Schedule A (each a “PURCHASER” and collectively the “PURCHASERS”), and Nationwide Health Properties, Inc., a Maryland corporation (the “SELLER”).

WHEREAS, the PURCHASERS desire to purchase from the SELLER, and the SELLER desires to issue and sell to the PURCHASERS, in the aggregate 125,000 shares of common stock of SELLER, par value $0.10 per share (the “Shares”), with the number of Shares acquired by each PURCHASER set forth on Schedule A.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties hereto agree as follows:

2. Representations and Warranties of PURCHASER. Each PURCHASER represents and warrants with respect to itself that:

3. Representations and Warranties of SELLER. The SELLER represents and

warrants that:

-2-

-3-

(g) The SELLER is not required to be registered under the Investment Company Act of 1940, as amended.

-4-

(l) The SELLER has good and marketable title to all of the properties and assets reflected in the audited financial statements contained in the Prospectus, subject

-5-

4. Representation and Warranty of the INVESTMENT ADVISER. To induce the SELLER to enter into this Agreement, the INVESTMENT ADVISER hereby represents and warrants that:

(a) It is an investment adviser duly registered with the SEC under the Investment Advisers Act of 1940.

(b) It has been duly authorized to act as investment adviser on behalf of each PURCHASER.

(d) This Agreement has been duly executed and delivered by INVESTMENT ADVISER and constitutes a legal, valid and binding agreement of INVESTMENT ADVISER, enforceable against it in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

-6-

the Closing, settlement shall occur through Jeffries & Company, or an affiliate thereof, on a delivery versus payment basis through the DTC ID System.

7. Governing Law. This Agreement shall be construed in accordance with and governed by the substantive laws of the State of New York, without regard to conflict of laws principles.

8 Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and may be amended only in a writing that is executed by each of the parties hereto.

-7-

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the date first above written.

NATIONWIDE HEALTH PROPERTIES, INC., a Maryland corporation


By:	/s/ MARK L. DESMOND
	Name:	Mark L. Desmond
	Title:	Senior Vice President & Chief Financial Officer

INVESTMENT ADVISER, on behalf of itself and each PURCHASER set forth on Schedule A


By:	/s/ PAUL GRAY
	Name:	Paul Gray
	Title:	Executive Vice President

-8-

EX-99.4 6 dex994.htm PURCHASE AGREEMENT DATED APRIL 29, 2003 Purchase Agreement dated April 29, 2003

EXHIBIT 99.4

PURCHASE AGREEMENT

This Purchase Agreement (this “Agreement”), dated as of April 29, 2003, is by and between Millennium Trading Co. LP ( the “PURCHASER”) and Nationwide Health Properties, Inc., a Maryland corporation (the “SELLER”).

WHEREAS, the PURCHASER desires to purchase from the SELLER, and the SELLER desires to issue and sell to the PURCHASER, 250,000 shares of common stock of SELLER, par value $0.10 per share (the “Shares”).

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties hereto agree as follows:

2 Representations and Warranties of PURCHASER. The PURCHASER represents and warrants that:

3. Representations and Warranties of SELLER. The SELLER represents and warrants that:

(a) The SELLER meets the requirements for use of Form S-3 under the

Securities Act of 1933, as amended (the “Act”). The SELLER’s Registration Statement (as defined below) was declared effective by the by the SEC (as defined below) and the SELLER has filed such post-effective amendments thereto as may be required prior to the execution of this Agreement and each such post-effective amendment became effective. The SEC has not issued, and to the SELLER’s knowledge, the SEC does not intend nor has it threatened to issue, a stop order with respect to the Registration Statement, nor has it otherwise suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, nor, to the SELLER’s knowledge, does it intend or has it threatened to do so. On the effective date, (i) the Registration Statement complied in all material respects with the requirements of the Act and the rules and regulations promulgated under the Act (the “Regulations”); at the effective date the Basic Prospectus (as defined below) complied, and at the Closing (as defined below) the Prospectus (as defined below) will comply, in all material respects with the requirements of the Act and the Regulations; and (ii) the Registration Statement at the effective date and as amended or supplemented on the date hereof and at the Closing did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus as of any such time, did not, does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall not apply to statements in or omissions from the Prospectus made in reliance upon and in conformity with information furnished to the SELLER in writing by the PURCHASER or Cohen & Steers Capital Advisors, LLC, in its capacity as placement agent, and their respective affiliates, expressly for use in the Prospectus. As used in this Agreement, the term “Registration Statement” means the “shelf” registration statement on Form S-3 (File No. 333-17061) as declared effective by the Securities and Exchange Commission (the “SEC”), including exhibits, financial statements, schedules and documents incorporated by reference therein. The term “Basic Prospectus” means the prospectus included in the Registration Statement. The term “Prospectus Supplement” means the prospectus supplement specifically relating to the Shares as shall be filed with the SEC pursuant to Rule 424 under the Act in connection with the sale of the Shares hereunder. The term “Prospectus” means the Basic Prospectus and the Prospectus Supplement. Any reference in this Agreement to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein as of the date hereof or the date of the Prospectus, as the case may be, and any reference herein to any amendment or supplement to the Registration Statement or the Prospectus shall be deemed to refer to and include any documents filed after such date and through the date of such amendment or supplement under the Securities Exchange Act of 1934, as amended (the “Exchange

-2-

Act”) and so incorporated by reference.

-3-

subject to preemptive or other similar rights.

(g) The SELLER is not required to be registered under the Investment Company Act of 1940, as amended.

-4-

business prospects of the SELLER and its Subsidiaries considered as one enterprise, or which is more likely than not to materially and adversely affect their respective property or assets or which is more likely than not to materially and adversely affect the consummation of this Agreement; all pending legal or governmental proceedings to which the SELLER or any of its Subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the Prospectus, including ordinary routine litigation incidental to its business, are, considered in the aggregate, not material to the business of the SELLER and its Subsidiaries considered as one enterprise.

-5-

SELLER’s properties creating obligations of the SELLER with respect to proceeds of the properties, environmental liabilities and other customary protections for the mortgagees.

4. Conditions to Obligations of the Parties. As a condition to Closing, (i) each of the representations and warranties of the parties hereto shall be true and correct in all material respects, (ii) the New York Stock Exchange shall have approved the Shares for listing upon notice of issuance, (iii) the PURCHASER shall have received an opinion from O’Melveny & Myers LLP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit A, (iv) the PURCHASER shall have received an opinion from Venable, Baetjer and Howard, LP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit B and (v) the PURCHASER shall have received a comfort letter from Ernst & Young LLP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit C.

6. Governing Law. This Agreement shall be construed in accordance with and governed by the substantive laws of the State of New York, without regard to conflict of laws principles.

-6-

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the date first above written.

NATIONWIDE HEALTH PROPERTIES, INC., a Maryland corporation


By:	/s/ MARK L. DESMOND
	Name:	Mark L. Desmond
	Title:	Senior Vice President & Chief Financial Officer

MILLENNIUM TRADING CO. LP


By:	/s/ TERRY FEENEY
	Name:	Terry Feeney
	Title:	Chief Operating Officer

-7-

EX-99.5 7 dex995.htm PURCHASE AGREEMENT DATED APRIL 29, 2003 Purchase Agreement dated April 29, 2003

EXHIBIT 99.5

PURCHASE AGREEMENT

This Purchase Agreement (this “Agreement”), dated as of April 29, 2003, is by and among Morgan Stanley Investment Management, Inc. (“INVESTMENT ADVISER”) on behalf of the client accounts of INVESTMENT ADVISER, as set forth on Schedule A (each a “PURCHASER” and collectively the “PURCHASERS”), and Nationwide Health Properties, Inc., a Maryland corporation (the “SELLER”).

WHEREAS, the PURCHASERS desire to purchase from the SELLER, and the SELLER desires to issue and sell to the PURCHASERS, in the aggregate 3,350,000 shares of common stock of SELLER, par value $0.10 per share (the “Shares”), with the number of Shares acquired by each PURCHASER set forth on Schedule A.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties hereto agree as follows:

2. Representations and Warranties of PURCHASER. The Investment Adviser represents and warrants, with respect to each PURCHASER:

(a) Due Authorization. Such PURCHASER is duly authorized to purchase the Shares. This Agreement has been duly authorized, executed and delivered by the Investment Adviser on behalf of such PURCHASER and constitutes a legal, valid and binding agreement of such PURCHASER, enforceable against such PURCHASER in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

(b) Prospectus and Prospectus Supplement. The Investment Adviser, on behalf of each such PURCHASER has received a copy of the SELLER’s Basic Prospectus (as defined below) dated April 19, 1998, and Prospectus Supplement (as defined below) dated April 29, 2003.

(c) Ownership of Shares of Common Stock. As of the date hereof, to the best of the knowledge of the Investment Adviser, none of the PURCHASERS, together with their respective subsidiaries and affiliates, owns 5% or more of the issued and outstanding shares of common stock, par value $0.10 per share, of the SELLER.

3. Representations and Warranties of SELLER. The SELLER represents and warrants that:

-2-

Prospectus, as the case may be, and any reference herein to any amendment or supplement to the Registration Statement or the Prospectus shall be deemed to refer to and include any documents filed after such date and through the date of such amendment or supplement under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and so incorporated by reference.

-3-

and when issued and delivered as contemplated hereby, will be validly issued, fully paid and non-assessable and will be listed, subject to notice of issuance, on the New York Stock Exchange, effective as of the Closing; the Shares conform to all statements relating thereto contained in the Prospectus; and the issuance of the Shares is not subject to preemptive or other similar rights.

(g) The SELLER is not required to be registered under the Investment Company Act of 1940, as amended.

(h) There is no action, suit or proceeding before or by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge

-4-

of the SELLER, threatened or contemplated, against or affecting the SELLER or any of its Subsidiaries, which is required to be disclosed in the Prospectus (other than as disclosed therein), or which is more likely than not to result in any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the SELLER and its Subsidiaries considered as one enterprise, or which is more likely than not to materially and adversely affect their respective property or assets or which is more likely than not to materially and adversely affect the consummation of this Agreement; all pending legal or governmental proceedings to which the SELLER or any of its Subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the Prospectus, including ordinary routine litigation incidental to its business, are, considered in the aggregate, not material to the business of the SELLER and its Subsidiaries considered as one enterprise.

(l) The SELLER has good and marketable title to all of the properties and

-5-

assets reflected in the audited financial statements contained in the Prospectus, subject to no lien, mortgage, pledge or encumbrance of any kind except those reflected in such financial statements (or as otherwise described in the Prospectus) or which are not material or which constitute customary provisions of mortgage loans secured by the SELLER’s properties creating obligations of the SELLER with respect to proceeds of the properties, environmental liabilities and other customary protections for the mortgagees.

4. Representation and Warranty of the INVESTMENT ADVISER. To induce the SELLER to enter into this Agreement, the INVESTMENT ADVISER hereby represents and warrants that:

(a) It is an investment adviser duly registered with the SEC under the Investment Advisers Act of 1940.

(b) It has been duly authorized to act as investment adviser on behalf of each PURCHASER.

6. Closing. The transactions contemplated hereby shall be consummated on May 2, 2003, or such other time as shall be agreed upon by the INVESTMENT ADVISER and the

-6-

SELLER (such time and date of payment and delivery being herein called the “Closing”). At the Closing, settlement shall occur through Jeffries & Company, or an affiliate thereof, on a delivery versus payment basis through the DTC ID System.

7. Governing Law. This Agreement shall be construed in accordance with and governed by the substantive laws of the State of New York, without regard to conflict of laws principles.

-7-

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the date first above written.

NATIONWIDE HEALTH PROPERTIES, INC., a Maryland corporation


By:		/s/ MARK L. DESMOND
		Name: MARK L. DESMOND Title: Senior Vice President & Chief Financial Officer

INVESTMENT ADVISER, on behalf of itself and each PURCHASER set forth on Schedule A


By:		/s/ THEODORE R. BIGMAN
		Name: Theodore R. Bigman Title: Managing Director

-8-

EX-99.6 8 dex996.htm PURCHASE AGREEMENT DATED APRIL 29, 2003 Purchase Agreement dated April 29, 2003

EXHIBIT 99.6

PURCHASE AGREEMENT

This Purchase Agreement (this “Agreement”), dated as of April 29, 2003, is by and among Security Capital Research & Management Incorporated (“INVESTMENT ADVISER”), the client accounts of INVESTMENT ADVISER, as set forth on Schedule A (each a “PURCHASER” and collectively the “PURCHASERS”), and Nationwide Health Properties, Inc., a Maryland corporation (the “SELLER”).

WHEREAS, the PURCHASERS desire to purchase from the SELLER, and the SELLER desires to issue and sell to the PURCHASERS, in the aggregate 3,000,000 shares of common stock of SELLER, par value $0.10 per share (the “Shares”), with the number of Shares acquired by each PURCHASER set forth on Schedule A.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties hereto agree as follows:

2. Representations and Warranties of INVESTMENT ADVISER. The INVESTMENT ADVISER Regarding the PURCHASERS, with discretionary authority from each of the PURCHASERS, hereby warrants that:

(a) Due Authorization. Each PURCHASER is duly authorized to purchase the Shares. This Agreement has been duly authorized, executed and delivered by each PURCHASER and constitutes a legal, valid and binding agreement of each PURCHASER, enforceable against each PURCHASER in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

(b) Prospectus and Draft Prospectus Supplement. The INVESTMENT ADVISER has received a copy of the SELLER’s Basic Prospectus (as defined below) dated April 19, 1998, and a draft Prospectus Supplement (as defined below) dated April 29, 2003.

(c) Ownership of Shares of Common Stock. As of the date hereof, based on the actual knowledge of the INVESTMENT ADVISER, no PURCHASER, together with its respective subsidiaries and affiliates, owns 5% or more of the issued and outstanding shares of common stock, par value $0.10 per share, of the SELLER.

3. Representations and Warranties of SELLER. The SELLER represents and warrants that:

(a) The SELLER meets the requirements for use of Form S-3 under the Securities Act of 1933, as amended (the “Act”). The SELLER’s Registration Statement (as defined below) was declared effective by the by the SEC (as defined below) and the SELLER has filed such post-effective amendments thereto as may be required prior to the execution of this Agreement and each such post-effective amendment became effective. The SEC has not issued, and to the SELLER’s knowledge, the SEC does not intend nor has it threatened to issue, a stop order with respect to the Registration Statement, nor has it otherwise suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, nor, to the SELLER’s knowledge, does it intend or has it threatened to do so. On the effective date, (i) the Registration Statement complied in all material respects with the requirements of the Act and the rules and regulations promulgated under the Act (the “Regulations”); at the effective date the Basic Prospectus (as defined below) complied, and at the Closing (as defined below) the Prospectus (as defined below) will comply, in all material respects with the requirements of the Act and the Regulations; and (ii) the Registration Statement at the effective date and as amended or supplemented on the date hereof and at the Closing did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus as of any such time, did not, does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall not apply to statements in or omissions from the Prospectus made in reliance upon and in conformity with information furnished to the SELLER in writing by any of the PURCHASERS expressly for use in the Prospectus. As used in this Agreement, the term “Registration Statement” means the “shelf” registration statement on Form S-3 (File No. 333-17061) as declared effective by the Securities and Exchange Commission (the “SEC”), including exhibits, financial statements, schedules and documents incorporated by reference therein. The term “Basic Prospectus” means the prospectus included in the Registration Statement. The term “Prospectus Supplement” means the prospectus supplement specifically relating to the Shares as shall be filed with the SEC pursuant to Rule 424 under the Act in connection with the sale of the Shares hereunder. The term “Prospectus” means the Basic Prospectus and the Prospectus Supplement. Any reference in this Agreement to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein as of the date hereof or the date of the Prospectus, as the case may be, and any reference herein to any amendment or supplement to the

-2-

Registration Statement or the Prospectus shall be deemed to refer to and include any documents filed after such date and through the date of such amendment or supplement under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and so incorporated by reference.

-3-

York Stock Exchange, effective as of the Closing; the Shares conform to all statements relating thereto contained in the Prospectus; and the issuance of the Shares is not subject to preemptive or other similar rights.

(g) The SELLER is not required to be registered under the Investment Company Act of 1940, as amended.

-4-

-5-

SELLER’s properties creating obligations of the SELLER with respect to proceeds of the properties, environmental liabilities and other customary protections for the mortgagees.

(m) The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, when they became effective or at the time they were filed with the SEC, complied in all material respects with the requirements of the Act and the Regulations or Exchange Act and the rules and regulations of the SEC thereunder (the “1934 Act Regulations”), as applicable, and, when read together with the other information in the Prospectus, at the time the Registration Statement became effective, at the time the Prospectus was issued and at the Closing, did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

(n) The accountants who certified the financial statements and supporting schedules included in the Registration Statement are independent public accountants as required by the Act and the Regulations.

(o) The financial statements included in the Registration Statement and the Prospectus, together with the related schedules and notes, present fairly the financial position of the SELLER and its consolidated subsidiaries at the dates indicated and the statement of operations, stockholders’ equity and cash flows of the SELLER and its consolidated subsidiaries for the periods specified; said financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout the periods involved. The supporting schedules, if any, included in the Registration Statement and Prospectus present fairly in accordance with GAAP the information required to be stated therein. The selected financial data and the summary financial information included in the Registration Statement and Prospectus present fairly the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included in the Registration Statement and Prospectus. In addition, any pro forma financial information included in the Registration Statement and the Prospectus present fairly the information shown therein, have been prepared in accordance with the SEC’s rules and guidelines with respect to pro forma financial statements and have been properly compiled on the bases described therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein. All historical financial statements and information and all pro forma financial statements and information relating to the SELLER or any entity acquired or to be acquired by the SELLER required by the Act, the Regulations, the Exchange Act and the 1934 Act Regulations

-6-

are included, or incorporated by reference, in the Registration Statement and Prospectus.

4. Representation and Warranty of the INVESTMENT ADVISER Regarding the INVESTMENT ADVISER. To induce the SELLER to enter into this Agreement, the INVESTMENT ADVISER hereby represents and warrants that:

(a) It is an investment adviser duly registered with the SEC under the Investment Advisers Act of 1940.

(b) It has been duly authorized to act as investment adviser on behalf of each PURCHASER.

5. Conditions to Obligations of the Parties. As a condition to Closing, (i) each of the representations and warranties of the parties hereto shall be true and correct in all respects, (ii) the New York Stock Exchange shall have approved the Shares for listing upon notice of issuance, (iii) the PURCHASERS shall have received an opinion from O’Melveny & Myers LLP, dated as of May 1, 2003, substantially in the form attached hereto as Exhibit A, (iv) the PURCHASERS shall have received an opinion from Venable, Baetjer & Howard, LP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit B, (v) the PURCHASERS shall have received a comfort letter from Ernst & Young LLP, dated as of May 2, 2003, substantially in the form attached hereto as Exhibit C, (vi) the PURCHASERS shall have received the Officer’s Certificate substantially in the form attached hereto as Exhibit D and (vii) the PURCHASERS shall have received the Secretary’s Certificate substantially in the form attached hereto as Exhibit E.

6 Closing. The transactions contemplated hereby shall be consummated on May 2, 2003, or such other time as shall be agreed upon by the INVESTMENT ADVISER and the SELLER (such time and date of payment and delivery being herein called the “Closing”). At the Closing, settlement shall occur through Jeffries & Company, or an affiliate thereof, on a

-7-

delivery versus payment basis through the DTC ID System.

7. Governing Law. This Agreement shall be construed in accordance with and governed by the substantive laws of the State of New York, without regard to conflict of laws principles.

-8-

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the date first above written.

NATIONWIDE HEALTH PROPERTIES, INC., a Maryland corporation

By:		/s/ MARK L. DESMOND
		Name: Mark L. Desmond Title: Senior Vice President & Chief Financial Officer

INVESTMENT ADVISER, on behalf of itself and each PURCHASER set forth on Schedule A

By:		/s/ KENNETH STATZ
		Name: Kenneth Statz Title: Managing Director

-9-

EX-99.7 9 dex997.htm PURCHASE AGREEMENT DATED APRIL 29, 2003 Purchase Agreement dated April 29, 2003

EXHIBIT 99.7

PURCHASE AGREEMENT

This Purchase Agreement (this “Agreement”), dated as of April 29, 2003, is by and among Nationwide Health Properties, Inc., a Maryland corporation (the “SELLER”), and Teachers Insurance and Annuity Association of America (“TIAA”), TIAA-CREF Real Estate Securities Fund and TIAA Life Real Estate Securities Fund, which funds are acting through their investment manager, Teachers Advisors, Inc., (each a “PURCHASER” and collectively the “PURCHASERS”), and Teachers Advisors, Inc. (the “INVESTMENT ADVISER”) entering into this Agreement on behalf of itself (as to paragraph 4 of this Agreement) and each of the funds listed under its name on Schedule A.

WHEREAS, the PURCHASERS desire to purchase from the SELLER, and the SELLER desires to issue and sell to the PURCHASERS, in the aggregate 2,050,000 shares of common stock of SELLER, par value $0.10 per share (the “Shares”), with the number of Shares acquired by each PURCHASER set forth on Schedule A.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties hereto agree as follows:

2. Representations and Warranties of PURCHASER. Each PURCHASER represents and warrants with respect to itself that:

share, of the SELLER.

3. Representations and Warranties of SELLER. The SELLER represents and warrants that:

-2-

the Registration Statement or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein as of the date hereof or the date of the Prospectus, as the case may be, and any reference herein to any amendment or supplement to the Registration Statement or the Prospectus shall be deemed to refer to and include any documents filed after such date and through the date of such amendment or supplement under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and so incorporated by reference.

-3-

common stock and preferred stock of SELLER have been duly authorized and validly issued and are fully paid and non-assessable; the Shares have been duly authorized, and when issued and delivered as contemplated hereby, will be validly issued, fully paid and non-assessable and will be listed, subject to notice of issuance, on the New York Stock Exchange, effective as of the Closing; the Shares conform to all statements relating thereto contained in the Prospectus; and the issuance of the Shares is not subject to preemptive or other similar rights.

(g) The SELLER is not required to be registered under the Investment Company Act of 1940, as amended.

-4-

(h) There is no action, suit or proceeding before or by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the SELLER, threatened or contemplated, against or affecting the SELLER or any of its Subsidiaries, which is required to be disclosed in the Prospectus (other than as disclosed therein), or which is more likely than not to result in any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the SELLER and its Subsidiaries considered as one enterprise, or which is more likely than not to materially and adversely affect their respective property or assets or which is more likely than not to materially and adversely affect the consummation of this Agreement; all pending legal or governmental proceedings to which the SELLER or any of its Subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the Prospectus, including ordinary routine litigation incidental to its business, are, considered in the aggregate, not material to the business of the SELLER and its Subsidiaries considered as one enterprise.

-5-

(l) The SELLER has good and marketable title to all of the properties and assets reflected in the audited financial statements contained in the Prospectus, subject to no lien, mortgage, pledge or encumbrance of any kind except those reflected in such financial statements (or as otherwise described in the Prospectus) or which are not material or which constitute customary provisions of mortgage loans secured by the SELLER’s properties creating obligations of the SELLER with respect to proceeds of the properties, environmental liabilities and other customary protections for the mortgagees.

4. Representation and Warranty of the INVESTMENT ADVISER. To induce the SELLER to enter into this Agreement, the INVESTMENT ADVISER hereby represents and warrants that:

(a) It is an investment adviser duly registered with the SEC under the Investment Advisers Act of 1940.

(b) It has been duly authorized to act as investment adviser on behalf of the client accounts listed as PURCHASERS under its name on Schedule A hereto.

(c) It has the power and authority to enter into and execute this Agreement on behalf of the client accounts listed as PURCHASERS under its name on Schedule A hereto.

(d) This Agreement has been duly executed and delivered by it and constitutes a legal, valid and binding agreement of the INVESTMENT ADVISER, enforceable against it in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

-6-

6. Closing. The transactions contemplated hereby shall be consummated on May 2, 2003, or such other time as shall be agreed upon by the INVESTMENT ADVISER and the SELLER (such time and date of payment and delivery being herein called the “Closing”). At the Closing, settlement shall occur through Jeffries & Company, or an affiliate thereof, on a delivery versus payment basis through the DTC ID System.

7. Governing Law. This Agreement shall be construed in accordance with and governed by the substantive laws of the State of New York, without regard to conflict of laws principles.

-7-

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the date first above written.

NATIONWIDE HEALTH PROPERTIES, INC., a Maryland corporation


By:		/s/ MARK L. DESMOND
	Name:	Mark L. Desmond
	Title:	Senior Vice President & Chief Financial Officer

TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA


By:		/s/ RICHARD C. GEORGE
	Name:	Richard C. George
	Title:	Associate Director

TEACHERS ADVISORS, INC., on behalf of itself (solely with respect to paragraph 4) and each Purchaser set forth under its name on Schedule A


By:		/s/ MARK L. SERLEN
	Name:	Mark L. Serlen
	Title:	Assistant Secretary

-8-

EX-99.8 10 dex998.htm PLACEMENT AGENCY AGREEMENT Placement Agency Agreement

EXHIBIT 99.8

April 29, 2003

Cohen & Steers Capital Advisors, LLC

757 Third Avenue

New York, New York 10017

Re: Placement of Securities of Nationwide Health Properties, Inc.

Dear Sirs:

This letter (the “Agreement”) confirms our agreement that Cohen & Steers Capital Advisors, LLC (the “Placement Agent”) has been retained by Nationwide Health Properties, Inc., a Maryland corporation (the “Company”), to act as the Company’s exclusive agent in connection with an offering (the “Offer”) of shares of common stock of the Company, par value $0.10 per share (the “Securities”). The engagement described herein (i) may be terminated by the Company at any time prior to the Closing Date (as defined below) and (ii) shall be in accordance with applicable laws and pursuant to the following procedures and terms and conditions:

1. The

Company will:

(a) Cause the Company’s independent public accountants to address and deliver to the Company and the Placement Agent (i) a letter (which letter is frequently referred to as a “comfort letter”) delivered on and dated the date hereof and (ii) a “bring-down” letter, delivered on and dated the date on which the sale of all of the Securities is consummated (the “Closing Date” and the time of such consummation on the Closing Date, the “Closing”) pursuant to those certain Purchase Agreements dated the date hereof between the Company and the purchasers party thereto (the “Purchasers”), which, with respect to the letter referred to in clause (i) above, will be substantially in the form attached hereto as Annex I, and with respect to the letter, referred to in clause (ii) above, will be in form and substance reasonably satisfactory to the Placement Agent.

(b) On the Closing Date, cause outside counsel to the Company to deliver opinions to the Placement Agent and the Purchasers substantially in the form of Annex II and Annex III hereto.

(c) As soon as practicable, apply for listing the Securities for trading on the New York Stock Exchange, Inc. (“NYSE”) and will use its best efforts to obtain approval from the NYSE with respect to such listing on or prior to the Closing Date.

(d) Prior to the Closing, the Company shall not sell or approve the solicitation of offers for the purchase of additional Securities in excess of the amount which shall be authorized by the Company or in excess of the aggregate offering price of the Securities registered pursuant to the Registration Statement (as defined below).

2. The Company authorizes the Placement Agent to use the Prospectus (as defined below) in connection with the Offer for such period of time as any such materials are required by law to be delivered in connection therewith and the Placement Agent agrees to do so.

3. (a) The Placement Agent will use commercially reasonable best efforts on behalf of the Company in connection with the Placement Agent’s services hereunder. No offers or sales of Securities shall be made to any person without the prior approval of such person by the Company, such approval to be at the reasonable discretion of the Company. The Placement Agent’s aggregate fee for its services hereunder will be equal to 2 % of the aggregate gross proceeds from the sale of the Securities (the “Fee”). Such Fee with respect to any Securities shall be payable by the Company at and subject to the consummation of the Closing Date. The Placement Agent will not enter into any agreement or arrangement with any broker, dealer or other person in connection with the placement of Securities (collectively, “participating person(s)”) which will obligate the Company to pay additional fees or expenses to or on behalf of a participating person without the prior written consent of the Company, it being understood that Jeffries & Company will be acting as settlement agent (“Settlement Agent”) in connection with the Offer and the Company will pay the fees and expenses of the Settlement Agent in connection therewith.

(b) The Company agrees that it will pay the reasonable costs and expenses incident to the performance of the obligations hereunder whether or not any Securities are offered or sold pursuant to the Offer, including, without limitation (i) all reasonable and customary mailing and handling costs and expenses incurred by dealers and brokers (including reasonable fees of your counsel) (subject to the last sentence of paragraph 3(a)), commercial banks, trust companies and nominees incurred in forwarding the Prospectus to their customers, (ii) the filing fees and expenses, if any, incurred with respect to any filing with the NYSE, (iii) all costs and expenses incident to the preparation, issuance, execution and delivery of the Securities, (iv) all costs and expenses (including filing fees) incident to the preparation, printing and filing under the Securities Act of 1933, as amended (the “Act”), of the Registration Statement and the Prospectus, including, without limitation, in each case, all exhibits, amendments and supplements thereto, (v) all costs and expenses incurred in connection with the required registration or qualification of the Securities issuable under the laws of such jurisdictions as the Placement Agent may designate, if any (including, without limitation, reasonable fees of counsel for the Placement Agent and its reasonable disbursements), (vi) all costs and expenses incurred by the Company in connection with the printing (including word

processing and duplication costs) and delivery of the Prospectus and Registration Statement (including, without limitation, any preliminary and supplemental blue sky memoranda) including, without limitation, mailing and shipping, (vii) all fees and expenses incurred in marketing the Offer, and (viii) the fees and disbursements of counsel to the Company and auditors to the Company. In addition, the Company agrees to reimburse the Placement Agent for reasonable out-of-pocket expenses of the Placement Agent in connection with the Offer, including, without limitation, the reasonable legal fees, expenses and disbursements of the Placement Agent’s counsel in connection with the Offer, but the Company shall not in any event be liable to the Placement Agent for damages on account of loss of anticipated profits from the sale of the Securities.

4. The Company and the Placement Agent hereby agree as follows:

(a) The Company will indemnify and hold harmless the Placement Agent and each of its respective partners, directors, officers, associates, affiliates, subsidiaries, employees, consultants, attorneys and agents, and each person, if any, controlling the Placement Agent or any of its affiliates within the meaning of either Section 15 of the Act or Section 20 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), from and against any and all losses, claims, damages, liabilities or costs (and any reasonable legal or other expenses incurred by such Placement Agent in investigating or defending the same or in giving testimony or furnishing documents in response to a request of any government agency or to a subpoena) in any way relating to, arising out of or caused by any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or in the Prospectus or in any way relating to, arising out of or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. Such indemnity agreement shall not, however, apply to any such loss, claim, damage, liability, cost or expense (i) if such statement or omission was made in reliance upon or in conformity with information furnished in writing to the Company by the Placement Agent or its affiliates expressly for use in the Prospectus Supplement (including, without limitation, information about any of the Purchasers), or (ii) which is held in a final judgment of a court of competent jurisdiction (not subject to further appeal) to have arisen out of the gross negligence, willful misconduct or bad faith of the Placement Agent or any indemnitee described in this paragraph 4(a).

(b) The Placement Agent will indemnify and hold harmless the Company and each of its directors, officers, associates, affiliates, subsidiaries, employees, consultants, attorneys, agents, and each person controlling the Company or any of its affiliates within the meaning of either Section 15 of the Act or Section 20 of the Ex-

change Act from and against any and all losses, claims, damages, liabilities, costs or expenses (and any reasonable legal or other expenses incurred by such indemnitee in investigating or defending the same or in giving testimony or furnishing documents in response to a request of any government agency or to a subpoena) (i) which are held in a final judgment of a court of competent jurisdiction (not subject to further appeal) to have arisen out of the gross negligence, willful misconduct or bad faith of such Placement Agent or any of its respective partners, directors, officers, associates, affiliates, subsidiaries, employees, consultants, attorneys and agents, and each person, if any, controlling the Placement Agent or any of its affiliates within the meaning of Section 15 of the Act or Section 20 of the Exchange Act or (ii) relating to, arising out of or caused by any untrue statement or alleged untrue statement of a material fact contained in the Prospectus Supplement or in any way relating to, arising out of or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, if such statement or omission was made in reliance upon or in conformity with information furnished in writing to the Company by the Placement Agent or its affiliates expressly for use in the Prospectus Supplement, or (iii) which result from violations by the Placement Agent of law or of requirements, rules or regulations of federal or state securities regulators, self-regulatory associations or organizations in the securities industry, stock exchanges or organizations with similar functions or responsibilities with respect to securities brokers or dealers, as determined by a court of competent jurisdiction or applicable federal or state securities regulators, self-regulatory associations or organizations in the securities industry or stock exchanges or organizations, as applicable.

(c) If any action, proceeding or investigation is commenced as to which any indemnified party hereunder proposes to demand indemnification under this letter agreement, such indemnified party will notify the indemnifying party promptly. The indemnifying party shall have the right to retain counsel of its own choice (which counsel shall be reasonably satisfactory to the indemnified party) to represent it and such counsel shall, to the extent consistent with its professional responsibilities, cooperate with the indemnified party and any counsel designated by the indemnified party. The indemnifying party will not be liable under this letter agreement for any settlement of any claim against the indemnified party made without the indemnifying party’s written consent.

In order to provide for just and equitable contribution, if a claim for indemnification pursuant to this paragraph 4 is made but it is found in a final judgment by a court of competent jurisdiction (not subject to further appeal) that such indemnification may not be enforced in such case, even though the express provisions hereof provided for indemnification

in such case, then the Company, on the one hand, and the Placement Agent, on the other hand, shall contribute to the losses, claims, damages, liabilities or costs to which the indemnified persons may be subject in accordance with the relative benefits received from the offering and sale of the Securities by the Company, on the one hand, and the Placement Agent, on the other hand (it being understood that, with respect to the Placement Agent, such benefits received are limited to fees actually paid by the Company and received by the Placement Agent pursuant to this Agreement), and also the relative fault of the Company, on the one hand, and the Placement Agent, on the other hand, in connection with the statements, acts or omissions which resulted in such losses, claims, damages, liabilities or costs, and the relevant equitable considerations shall also be considered. No person found liable for a fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who is not also found liable for such fraudulent misrepresentation. Notwithstanding the foregoing, the Placement Agent shall not be obligated to contribute any amount hereunder that exceeds the fees received by the Placement Agent in respect to the offering and sale of the Securities.

5. The Company represents and warrants to the Placement Agent as of the date hereof and as of the Closing Date as follows:

(a) The Company meets the requirements for use of Form S-3 under the Act. The Company’s Registration Statement (as defined below) was declared effective by the SEC (as defined below) and the Company has filed such post-effective amendments thereto as may be required prior to the execution of this Agreement and each such post-effective amendment became effective. The SEC has not issued, and to the Company’s knowledge, the SEC does not intend nor has it threatened to issue, a stop order with respect to the Registration Statement, nor has it otherwise suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, nor, to the Company’s knowledge, does it intend or has it threatened to do so. On the effective date, (i) the Registration Statement complied in all material respects with the requirements of the Act and the rules and regulations promulgated under the Act (the “Regulations”); at the effective date the Basic Prospectus (as defined below) complied, and at the Closing the Prospectus will comply, in all material respects with the requirements of the Act and the Regulations; and (ii) the Registration Statement at the effective date and as amended or supplemented on the date hereof and at the Closing Date did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus as of any such time, did not, does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however,

that the representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement or the Prospectus made in reliance upon and in conformity with information furnished to the Company in writing by (i) the Placement Agent or its affiliates or (ii) by any of the Purchasers or any of their respective affiliates, in each case, expressly for use therein. As used in this Agreement, the term “Registration Statement” means the “shelf” registration statement on Form S-3 (File No. 333-17061) as declared effective by the Securities and Exchange Commission (the “SEC”), including exhibits, financial statements, schedules and documents incorporated by reference therein. The term “Basic Prospectus” means the prospectus included in the Registration Statement. The term “Prospectus Supplement” means the prospectus supplement specifically relating to the Securities as shall be filed with the SEC pursuant to Rule 424 under the Act in connection with the sale of the Securities. The term “Prospectus” means the Basic Prospectus and the Prospectus Supplement. Any reference in this Agreement to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein as of the date hereof or the date of the Prospectus, as the case may be, and any reference herein to any amendment or supplement to the Registration Statement or the Prospectus shall be deemed to refer to and include any documents filed after such date and through the date of such amendment or supplement under the Exchange Act and so incorporated by reference.

(b) Since the date as of which information is given in the Registration Statement and the Prospectus, except as otherwise stated therein, (A) there has been no material adverse change or any development involving a prospective material adverse change in or affecting the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and the subsidiaries of the Company, if any (the “Subsidiaries”) considered as one enterprise, whether or not arising in the ordinary course of business, (B) there have been no transactions entered into by the Company or any of its Subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its Subsidiaries considered as one enterprise, and (C) other than regular quarterly dividends, there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock.

(c) The Company has been duly incorporated and is validly existing in good standing under the laws of the State of Maryland. Each Subsidiary of the Company has been duly organized and is validly existing in good standing under the laws of its jurisdiction of organization. Each of the Company and its Subsidiaries has corporate, limited partnership or limited liability company power and authority, as the case may be, to own and lease its properties and to conduct its business as described in the

Prospectus; and each of the Company and its Subsidiaries is duly qualified to transact business in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify would not have a material adverse effect on the condition, financial or otherwise, or the earnings, business affairs or business prospects of the Company and its Subsidiaries considered as one enterprise.

(d) As of the date hereof, the authorized capital stock of the Company consisted of 100,000,000 shares of common stock, par value $0.10 per share, and 5,000,000 shares of preferred stock, par value $1.00 per share, of which 49,172,216 shares of common stock and 1,000,000 shares of 7.677% Series A Cumulative Preferred Stock are issued and outstanding. The issued and outstanding shares of the Company’s common stock and preferred stock have been duly authorized and validly issued and are fully paid and non-assessable; the Securities have been duly authorized, and when issued and delivered as contemplated hereby, will be validly issued, fully paid and non-assessable and will be listed, subject to notice of issuance, on the NYSE, effective as of the Closing Date; the Securities and the shares of capital stock of the Company conform to all statements relating thereto contained in the Prospectus; and the issuance of the Securities is not subject to preemptive or other similar rights.

(e) Neither the Company nor any of its Subsidiaries is in violation of its organizational documents or in default in the performance or observance of any material obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, loan agreement, note, lease or other instrument or agreement to which the Company or any of its Subsidiaries is a party or by which it or any of them may be bound, or to which any of the property or assets of the Company or any of its Subsidiaries is subject where such violation or default would have a material adverse effect on the condition, financial or otherwise, or the earnings, business affairs or business prospects of the Company and its Subsidiaries considered as one enterprise; and, the execution, delivery and performance of this Agreement, and the issuance and delivery of the Securities and the consummation of the transactions contemplated herein have been duly authorized by all necessary action and will not conflict with or constitute a material breach of, or default under, or result in the creation or imposition of any material lien, charge or encumbrance upon any property or assets of the Company or any of its Subsidiaries pursuant to, any contract, indenture, mortgage, loan agreement, note, lease or other instrument or agreement to which the Company or any of its Subsidiaries is a party or by which it or any of them may be bound, or to which any of the property or assets of the Company or any of its Subsidiaries is subject, nor will any such action result in any violation of the provisions of the Amended and Restated Articles of Incorporation, as amended, Bylaws or other organizational documents of the Company or

any of its Subsidiaries or any applicable law, administrative regulation or administrative or court decree.

(f) The Company is organized in conformity with the requirements for qualification and, as of the date hereof and as of the Closing Date, operates in a manner that qualifies it as a “real estate investment trust” under the Internal Revenue Code of 1986, as amended, and the rules and regulations thereunder and will be so qualified after giving effect to the sale of the Securities.

(g) The Company is not required to be registered under the Investment Company Act of 1940, as amended.

(h) There is no action, suit or proceeding before or by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the Company, threatened or contemplated, against or affecting the Company or any of its Subsidiaries, which is required to be disclosed in the Prospectus (other than as disclosed therein), or which is more likely than not to result in any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its Subsidiaries considered as one enterprise, or which is more likely than not to materially and adversely affect their respective property or assets or which is more likely than not to materially and adversely affect the consummation of this Agreement; all pending legal or governmental proceedings to which the Company or any of its Subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the Prospectus, including ordinary routine litigation incidental to its business, are, considered in the aggregate, not material to the business of the Company and its Subsidiaries considered as one enterprise.

(i) No authorization, approval or consent of any court or United States federal or state governmental authority or agency is necessary in connection with the sale of the Securities hereunder, except such as may be required under the Act or the Regulations or state securities laws or real estate syndication laws.

(j) The Company and its Subsidiaries possess such material certificates, authorities or permits issued by the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct the business now conducted by them, and neither the Company nor any of its Subsidiaries has received any notice of proceedings relating to the revocation or modification of any such certificate, authority or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would materially and adversely affect the condition, financial or otherwise, or

the earnings, business affairs or business prospects of the Company and its Subsidiaries considered as one enterprise, nor, to the knowledge of the Company, are any such proceedings threatened or contemplated.

(k) The Company has corporate power and corporate authority to enter into this Agreement, and this Agreement has been duly authorized, executed and delivered by the Company and constitutes a legal, valid and binding agreement of the Company, enforceable against the Company in accordance with its terms except as may be limited by (i) the effect of bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights or remedies of creditors or (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law and the discretion of the court before which any proceeding therefor may be brought.

(l) The Company has good and marketable title to all of the properties and assets reflected in the audited financial statements contained in the Prospectus, subject to no lien, mortgage, pledge or encumbrance of any kind except those reflected in such financial statements (or as otherwise described in the Prospectus) or which are not material or which constitute customary provisions of mortgage loans secured by the Company’s properties creating obligations of the Company with respect to proceeds of the properties, environmental liabilities and other customary protections for the mortgagees.

(m) Any certificate signed by any officer of the Company and delivered to the Placement Agent or to counsel for the Placement Agent shall be deemed a representation and warranty by the Company to the Placement Agent as to the matters covered thereby.

6. The Placement Agent represents and warrants to the Company that, (i) it is registered as a broker-dealer under the Exchange Act and licensed or otherwise qualified to do business as a broker-dealer in all states in which it will offer any Securities pursuant to this Agreement, (ii) the Placement Agent is acting as the Company’s agent and not as principal in the Offer of the Securities, (iii) neither the Placement Agent nor any of its affiliates will participate as a Purchaser in the Offer, (iv) assuming compliance by the Company with all relevant provisions of the Act in connection with the Prospectus, the Placement Agent will conduct all offers and sales of the Securities in compliance with the relevant provisions of the Act and the Regulations and various state securities laws and regulations and (v) the Placement Agent will only act as agent in those jurisdictions in which it is authorized to do so.

7. This Agreement shall be governed by the laws of the State of New York governing contracts made and to be performed in such State without giving effect to principles of conflicts of law.

8. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be the same Agreement.

If the foregoing is in accord with your understanding of our agreement, please sign in the space provided below and return a signed copy of this letter to the Company.

Sincerely,

NATIONWIDE HEALTH PROPERTIES, INC.

By: /s/ MARK L. DESMOND

Name: Mark L. Desmond

Title: Chief Financial Officer and

Senior Vice President

Accepted by:

COHEN & STEERS CAPITAL

ADVISORS, LLC

By: /s/ BRADLEY G. RAZOOK

Name: Bradley G. Razook

Title: Managing Director

-----END PRIVACY-ENHANCED MESSAGE-----